(19)
(11) EP 4 489 751 A1

(12)

(43) Date of publication:
15.01.2025 Bulletin 2025/03

(21) Application number: 23767227.4

(22) Date of filing: 23.02.2023
(51) International Patent Classification (IPC): 
A61K 31/4174(2006.01)
A61K 31/192(2006.01)
A61P 43/00(2006.01)
 A61K 31/167(2006.01)
A61P 29/00(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 31/167; A61P 29/00; A61K 31/192; A61K 31/4174
 
C-Sets:
  1. A61K 31/167, A61K 2300/00;
  2. A61K 31/192, A61K 2300/00;
(86) International application number:
PCT/NZ2023/050026
(87) International publication number:
WO 2023/172148 (14.09.2023 Gazette 2023/37)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 08.03.2022 AU 2022201576

(71) Applicant: AFT Pharmaceuticals Limited
Auckland 0622 (NZ)

(72) Inventor:
  • ATKINSON, Hartley
    Auckland, 0622 (NZ)

(74) Representative: Latscha Schöllhorn Partner AG 
Grellingerstrasse 60
4052 Basel
4052 Basel (CH)

   


(54) MEDICATION